ZA98825B - Method of using neurotrophic carbamates and ureas - Google Patents

Method of using neurotrophic carbamates and ureas

Info

Publication number
ZA98825B
ZA98825B ZA98825A ZA98825A ZA98825B ZA 98825 B ZA98825 B ZA 98825B ZA 98825 A ZA98825 A ZA 98825A ZA 98825 A ZA98825 A ZA 98825A ZA 98825 B ZA98825 B ZA 98825B
Authority
ZA
South Africa
Prior art keywords
neurotrophic
ureas
carbamates
neurotrophic carbamates
Prior art date
Application number
ZA98825A
Other languages
English (en)
Inventor
Jia-He Li
Gregory S Hamilton
Joseph P Steiner
Original Assignee
Guilford Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guilford Pharm Inc filed Critical Guilford Pharm Inc
Publication of ZA98825B publication Critical patent/ZA98825B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA98825A 1997-02-27 1998-02-02 Method of using neurotrophic carbamates and ureas ZA98825B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80564697A 1997-02-27 1997-02-27

Publications (1)

Publication Number Publication Date
ZA98825B true ZA98825B (en) 1998-10-19

Family

ID=25192108

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA98825A ZA98825B (en) 1997-02-27 1998-02-02 Method of using neurotrophic carbamates and ureas

Country Status (9)

Country Link
EP (1) EP1001762A4 (ja)
JP (1) JP2001513772A (ja)
AR (1) AR011869A1 (ja)
AU (1) AU6181698A (ja)
CA (1) CA2281096A1 (ja)
PA (1) PA8447901A1 (ja)
PE (1) PE46599A1 (ja)
WO (1) WO1998037882A1 (ja)
ZA (1) ZA98825B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218424B1 (en) * 1996-09-25 2001-04-17 Gpi Nil Holdings, Inc. Heterocyclic ketone and thioester compounds and uses
US6242468B1 (en) * 1997-02-27 2001-06-05 Jia-He Li Carbamate and urea compositions and neurotrophic uses
AU756912B2 (en) 1998-07-17 2003-01-23 Agouron Pharmaceuticals, Inc. Compounds, compositions, and methods for stimulating neuronal growth and elongation
US6395758B1 (en) * 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US6376517B1 (en) * 1998-08-14 2002-04-23 Gpi Nil Holdings, Inc. Pipecolic acid derivatives for vision and memory disorders
US7338976B1 (en) * 1998-08-14 2008-03-04 Gpi Nil Holdings, Inc. Heterocyclic esters or amides for vision and memory disorders
US6323215B1 (en) 1999-07-09 2001-11-27 Ortho-Mcneil Pharmaceutical, Inc. Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods
JP2003504367A (ja) 1999-07-09 2003-02-04 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 神経栄養性ピロリジン類およびピペリジン類、並びに関連組成物および方法
WO2001004091A1 (en) 1999-07-09 2001-01-18 Ortho-Mcneil Pharmaceutical, Inc. Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods
CA2383086A1 (en) * 1999-09-08 2001-03-15 Joseph P. Steiner Non-peptidic cyclophilin binding compounds and their use
GT200000203A (es) 1999-12-01 2002-05-24 Compuestos, composiciones y metodos para estimular el crecimiento y elongacion de neuronas.
EP1339668A2 (en) * 2000-11-28 2003-09-03 Guilford Pharmaceuticals Inc. Bisubstituted carbocyclic cyclophilin binding compounds and theirus
US6656971B2 (en) * 2001-01-25 2003-12-02 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
EP1402888A1 (en) * 2002-09-18 2004-03-31 Jerini AG The use of substituted carbocyclic compounds as rotamases inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620971A (en) * 1991-05-09 1997-04-15 Vertex Pharmaceuticals Incorporated Biologically active acylated amino acid derivatives
US5744485A (en) * 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US6037370A (en) * 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5780484A (en) * 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds

Also Published As

Publication number Publication date
AR011869A1 (es) 2000-09-13
CA2281096A1 (en) 1998-09-03
WO1998037882A1 (en) 1998-09-03
PE46599A1 (es) 1999-05-12
EP1001762A1 (en) 2000-05-24
PA8447901A1 (es) 2000-05-24
EP1001762A4 (en) 2002-05-08
JP2001513772A (ja) 2001-09-04
AU6181698A (en) 1998-09-18

Similar Documents

Publication Publication Date Title
HK1022069A1 (en) Television schedule system and method of operation
PL333364A1 (en) Novel compounds and method of using them
PL318128A1 (en) Polymer-polyol and method of obtaining polymer-polyols
GB2311192B (en) Data-transmitter-receiver and method of operation
ZA98825B (en) Method of using neurotrophic carbamates and ureas
ZA989207B (en) Method of building and maintaining bone.
IL129696A0 (en) N-linked ureas and carbamates of heterocyclic thioesters
HUP0003114A3 (en) Method for the preparation of carbamates
NZ329160A (en) 3-amidochromanylsulphonyl(thio)ureas and their use
PL335903A1 (en) Improved method of obtaining thiazolydinodiones and novel thiazolydinodiones obtained thereby
GB2334317B (en) Fastening member and fabrication method thereof
GB2330478B (en) Receiver and method of construction
GB9706070D0 (en) Method of decomposing polychlorodibenzo-p-dioxins and/or polychlorodibenzofurans
EP0959882A4 (en) N-LINKED UREAS AND CARBAMATES OF HETEROCYCLIC THIOESTERS
IL129661A0 (en) Method and preparation of physostigmine carbamate derivatives from eseretholes
HUP0004295A3 (en) Method and apparatus for the manufacture of roof cladding elements
GB2329920B (en) Railway construction method and apparatus
ZA984534B (en) Method for the preparation of carbamates
GB9703779D0 (en) Reaction apparatus and method of using the same
GB2323619B (en) Substructure and method of installation
PL327389A1 (en) Novel seco-compounds of thylosine class and method of obtaining them
GB9602327D0 (en) Structure and method of construction
ZA958942B (en) Roof support and method of forming a roof support
EP0910476A4 (en) INJECTOR SYSTEM AND MANUFACTURING METHOD
PL315864A1 (en) Method of obtaining novell-aryl 3-(aryloimidazolyn-2-yl]ureas